FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Public Meeting on Breast Cancer Drug Development

[ Price : $8.95]

Federal Register Notice: FDA plans a public meeting 4/2 on patient-focused drug development for breast cancer.

Sen. Brown Urges FDA to Ban Powdered Caffeine

[ Price : $8.95]

Sen. Sherrod Brown (D-OH) calls on FDA to immediately ban the retail sales of powdered caffeine due to safety concerns.

Lundbeck Scraps Stroke Drug Development

[ Price : $8.95]

H. Lundbeck A/S discontinues developing its investigational ischemic stroke drug desmoteplase.

FDA 510(k) Cleared with CLIA Waiver for Quidel Strep Test

[ Price : $8.95]

FDA issues 510(k) clearance and a Clinical Laboratory Improvement Amendments waiver for Quidel Corp.s Sofia Strep A+ Fluorescent I...

FDA Increasing Inspection Staff in China

[ Price : $8.95]

FDA says it is increasing the number of drug and food inspectors posted in China.

Aptiom Print Ad Overstates Efficacy: OPDP

[ Price : $8.95]

CDERs Office of Prescription Drug Promotion says that a Sunovion DTC print ad for Aptiom misleadingly overstates the products effi...

Industry Using Political Clout to Block Biosimilars: Public Citizen

[ Price : $8.95]

Public Citizen says the biologics industry has used its political power to delay marketing of generic biologics.

FDA Sends Collection of Info on Fast-Track Drugs to OMB

[ Price : $8.95]

Federal Register Notice: FDA submits a proposed collection of information on a guidance on fast track drug development programs to...

Info on Orphan Products Sent to OMB

[ Price : $8.95]

Federal Register Notice: FDA submits a proposed collection of information to the Office of Management and Budget on a draft guidan...

Guidance on Study Data E-Submissions

[ Price : $8.95]

Federal Register Notice: FDA releases a guidance: Providing Regulatory Submissions in Electronic Format Standardized Study Data.